Business Description
KoBioLabs Inc
ISIN : KR7348150004
Share Class Description:
XKRX:348150: Ordinary SharesCompare
Compare
Traded in other countries / regions
348150.Korea IPO Date
2020-11-18Description
KoBioLabs Inc is a biotechnology company focused on Microbiome therapeutics. It is involved in the research of medicines for Immune, Metabolic and Neurological Diseases.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 0.6 | |||||
| Debt-to-EBITDA | 10.85 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.5 | |||||
| Beneish M-Score | 8.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 61.1 | |||||
| 3-Year EBITDA Growth Rate | 50.1 | |||||
| 3-Year EPS without NRI Growth Rate | 11.1 | |||||
| 3-Year FCF Growth Rate | -9.3 | |||||
| 3-Year Book Growth Rate | -12.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.41 | |||||
| 9-Day RSI | 36.2 | |||||
| 14-Day RSI | 41.77 | |||||
| 6-1 Month Momentum % | -18.34 | |||||
| 12-1 Month Momentum % | -22.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.39 | |||||
| Quick Ratio | 4.39 | |||||
| Days Inventory | 28.03 | |||||
| Days Sales Outstanding | 13.52 | |||||
| Days Payable | 0.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.7 | |||||
| Shareholder Yield % | -4.11 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.92 | |||||
| Operating Margin % | -0.97 | |||||
| Net Margin % | -21.24 | |||||
| FCF Margin % | -57.57 | |||||
| ROE % | -20.63 | |||||
| ROA % | -9.56 | |||||
| ROIC % | -0.8 | |||||
| ROC (Joel Greenblatt) % | 2.71 | |||||
| ROCE % | 1.07 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.59 | |||||
| PB Ratio | 3.2 | |||||
| Price-to-Tangible-Book | 3.2 | |||||
| EV-to-EBIT | 91.74 | |||||
| EV-to-EBITDA | 39.87 | |||||
| EV-to-Revenue | 1.8 | |||||
| EV-to-FCF | -3.12 | |||||
| Price-to-Net-Current-Asset-Value | 24.02 | |||||
| Earnings Yield (Greenblatt) % | 1.09 | |||||
| FCF Yield % | -22.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
KoBioLabs Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 52,110.62 | ||
| EPS (TTM) (â‚©) | -589.637 | ||
| Beta | 1.18 | ||
| Volatility % | 47.47 | ||
| 14-Day RSI | 41.77 | ||
| 14-Day ATR (â‚©) | 462.821991 | ||
| 20-Day SMA (â‚©) | 7717 | ||
| 12-1 Month Momentum % | -22.47 | ||
| 52-Week Range (â‚©) | 6330 - 14150 | ||
| Shares Outstanding (Mil) | 18.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
KoBioLabs Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
KoBioLabs Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
KoBioLabs Inc Frequently Asked Questions
What is KoBioLabs Inc(XKRX:348150)'s stock price today?
The current price of XKRX:348150 is â‚©7140.00. The 52 week high of XKRX:348150 is â‚©14150.00 and 52 week low is â‚©6330.00.
When is next earnings date of KoBioLabs Inc(XKRX:348150)?
The next earnings date of KoBioLabs Inc(XKRX:348150) is .
Does KoBioLabs Inc(XKRX:348150) pay dividends? If so, how much?
KoBioLabs Inc(XKRX:348150) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers